Nattokinase Supplements: Compare Labels, FU Potency & Value

Nattokinase (the enzyme)

Nattokinase is an enzyme associated with natto, the fermented soybean food. On a Supplement Facts panel, “nattokinase” identifies the ingredient. Because it is an enzyme, its relevant comparison value is its activity potency, not only its weight. Compare the declared potency and amount per serving consistently across products.

Fibrinolytic Units (FU)

Fibrinolytic Units (FU) are an activity-based measure used on some nattokinase labels to express potency — that is, how much enzyme activity a serving is declared to provide, rather than how much it weighs. A label that states an FU value is more specific about potency than one that lists only a milligram amount. This hub records FU where documented and does not invent or convert FU values to or from milligrams. FU and milligrams describe different things and are not interchangeable.

Milligram (mg) weight vs FU potency

A label may state a milligram amount of nattokinase, an FU potency, or both. Milligrams describe how much material a serving contains by weight; FU describes enzyme activity. Two products with the same milligram amount can differ in declared FU potency, and two products with the same FU value can differ in milligram weight. This hub does not treat the two as interchangeable and does not invent conversions between them. Compare whichever values the labels actually declare.

Common FU label values (e.g. 2000 FU, 4000 FU)

Some nattokinase labels declare potency values such as 2000 FU or 4000 FU per serving, among others. These are declared potency values to compare where documented. This hub does not imply that a higher FU value is automatically better, more effective, or a recommended dose, and does not endorse any particular FU value for any outcome. Compare the declared FU alongside the serving size, formulation, and testing.

Amount per serving

The Supplement Facts panel declares the amount of nattokinase per serving, by weight (milligrams) and/or by potency (FU) where stated. This is the value to compare across products in a single consistent unit. A higher amount or higher FU value is not automatically better — the relevant comparison is the declared value alongside the serving size, the formulation, and the testing behind the product.

Serving size & servings per container

A serving may be one capsule, one tablet, or more than one unit. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value. Two products with the same “2000 FU” claim can differ if one serving is one capsule and the other is two.

Capsules and tablets

A format choice. Capsules and tablets offer fixed servings. The format is a convenience and formulation choice, not a quality verdict — compare declared nattokinase potency per serving, servings per container, and additional ingredients together.

Combination formulas and added ingredients

Some products contain only nattokinase; others combine it with other enzymes, vitamins, minerals, or botanical extracts. A combination product is a different formulation, not a stronger version of the same nattokinase. Added ingredients carry their own considerations, separate from nattokinase alone. A clear ingredient list with named additives is part of HerbParlor’s transparency scoring. Missing or vague disclosure is reported as unavailable, not silently treated as a failure or a pass.

Nattokinase has been studied in laboratory, mechanistic, and a limited number of human studies, often in relation to fibrinolytic activity and measures of blood circulation or blood pressure. The summary below orients you; it is not a treatment or dosing recommendation, and results vary by study design, potency, amount, population, and the outcome studied. Laboratory and mechanistic findings are not established human health benefits. The human evidence base remains limited in size, duration, and the outcomes measured, and most human studies report surrogate or intermediate measures rather than clinical cardiovascular events.

What the research landscape looks like

• Mechanism — fibrinolytic activity in the laboratory

  Nattokinase is described in scientific literature as a fibrinolytic enzyme, and laboratory and mechanistic studies have examined its activity related to fibrin breakdown. These findings describe a biochemical property under controlled conditions; they are the starting point for research, not established clinical outcomes, and they do not show that a nattokinase supplement treats, prevents, or cures blood clots or any condition in people.

• Blood pressure measurements (human studies)

  Some randomized trials and systematic reviews have examined nattokinase in relation to blood pressure readings. Where systematic-review evidence reports blood-pressure effects, the reported changes are in measured blood pressure values — a surrogate outcome — and findings vary by study design, potency, amount, duration, and population, with some inconsistency across studies. A measured change in blood pressure is not a diagnosis or treatment claim, is not the same as established antihypertensive efficacy, and does not by itself establish a reduction in strokes, heart attacks, or other cardiovascular events. This hub does not present nattokinase as a treatment or preventive therapy for hypertension, and does not present it as a substitute for prescribed blood-pressure medication.

• Coagulation and fibrinolytic biomarkers

  Some human studies have measured coagulation or fibrinolytic biomarkers (for example markers related to fibrin, fibrinogen, or clotting activity) after nattokinase supplementation. Changes in these laboratory biomarkers are surrogate outcomes: they describe measured blood values, not clinical events. A biomarker change does not establish that nattokinase prevents or dissolves dangerous blood clots, and does not establish equivalence to prescription anticoagulants or antiplatelet medicines. This hub does not present nattokinase as a substitute for prescribed anticoagulants or antiplatelet drugs.

• Lipid and other surrogate biomarkers

  Some research has examined nattokinase in relation to lipid or other blood biomarkers. Where reported, these are surrogate measures, not clinical outcomes, and findings are not consistent across studies. A change in a lipid or other biomarker does not by itself establish a reduction in cardiovascular events, and this hub does not present such changes as proof that nattokinase treats, prevents, or cures cardiovascular disease or atherosclerosis.

• Cardiovascular clinical outcomes

  The available human research does not establish that nattokinase prevents or treats blood clots, stroke, heart attack, cardiovascular disease, hypertension, or atherosclerosis. Most human studies measure surrogate or intermediate outcomes (blood pressure, biomarkers) rather than actual cardiovascular events, and no clinical-event prevention has been demonstrated. This hub treats cardiovascular protection, clot prevention, stroke prevention, and heart-attack prevention as claims that have been investigated rather than as established clinical outcomes.

• Surrogate outcomes are not clinical outcomes

  A central limitation of the nattokinase evidence base is that changes in blood pressure, fibrinolytic markers, or lipids do not automatically translate into fewer cardiovascular events. Surrogate and intermediate outcomes can be hypothesis-generating, but they are not a substitute for clinical-event evidence. This hub keeps mechanism, biomarker/surrogate outcomes, intermediate physiological outcomes, and clinical outcomes distinct, and does not turn a biomarker or blood-pressure finding into a guaranteed health outcome.

• Human clinical evidence is limited

  The body of human clinical evidence for nattokinase remains limited in size, duration, and the outcomes measured, and much of the supporting interest comes from laboratory and animal or mechanistic work. Results are not yet sufficient to establish nattokinase as effective for any specific health outcome. This is a developing research area, not a settled one.

• Potency, amount, and study design

  Studies use different potencies (often expressed in FU), amounts, and study designs. A studied potency or amount is not a recommendation, and a higher FU value is not established as automatically more effective. Compare the declared potency and serving size together rather than treating any single value as a quality ranking.

• Bleeding risk

  Because nattokinase is described as a fibrinolytic enzyme and has been studied in relation to fibrin and blood clotting, there is a plausible concern about bleeding risk, particularly at higher potencies or amounts, in people with bleeding conditions, and when combined with blood-thinning medications. This is general orientation, not a treatment instruction. Discuss nattokinase use with a healthcare professional before starting if you have any bleeding-related concern.

• Blood-thinning (anticoagulant/antiplatelet) medications

  Nattokinase may interact with blood-thinning medications such as warfarin and other anticoagulants or antiplatelet drugs, and this interaction is discussed in authoritative sources. Anyone taking such a medication should discuss nattokinase use with the clinician managing that medication before starting. This is general orientation, not a treatment instruction.

• Blood pressure medications

  Some research has examined nattokinase in relation to blood pressure. If you take blood pressure medication or have a cardiovascular condition, discuss use with a healthcare professional before starting, as effects on blood pressure could interact with therapy.

• Surgery and dental procedures

  Because of the plausible bleeding concern, people preparing for surgery or dental procedures are commonly advised to discuss supplement use with their healthcare team and to follow guidance on stopping supplements ahead of a procedure.

• Pregnancy, nursing, and medical conditions

  Whether a nattokinase supplement is appropriate in pregnancy, while nursing, or alongside any medical condition or medication is a decision for a healthcare professional. This hub does not recommend a nattokinase product, potency, or amount for any specific situation or outcome.

• Reported effects and individual response

  Where human studies report effects, they have generally been limited and short-term. As with any supplement, individual responses can vary. If you experience persistent or worsening effects, stop use and discuss with a healthcare professional.

No single nattokinase product is “best” for everyone, and no nattokinase product is established as effective for any health outcome. These neutral criteria help you narrow the field to the products worth comparing side by side. They use only the facts HerbParlor already structures and scores — nothing here is influenced by affiliate availability, commission, merchant, or a sponsored ranking.

Potency declared in FU where documented

Whether the label states a Fibrinolytic Units (FU) value. FU expresses enzyme activity, not weight, and a label that states FU is more specific about potency than one that lists only milligrams. This hub does not invent or convert FU values, and does not treat FU and milligrams as interchangeable. Compare FU values only across products that declare them. A higher FU value is not automatically better and is not a recommendation.

Amount per serving

How much nattokinase a serving delivers, stated by weight (milligrams) and/or by potency (FU) where declared. Compare the declared value in a single consistent unit. A higher amount or higher FU value is not automatically better; compare it alongside the serving size, formulation, and testing.

Serving size

A serving may be one capsule, one tablet, or more than one unit. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value. Two products with the same “2000 FU” claim can differ if one serving is one capsule and the other is two.

Ingredient identity & formulation

Whether the label names “nattokinase” clearly, and whether the product contains only nattokinase or adds other enzymes, vitamins, minerals, or botanical extracts. A combination product is a different formulation, not a stronger version of the same nattokinase. Compare the declared potency and the full ingredient list together.

Combination ingredients

Where a product combines nattokinase with other ingredients, note what is added and at what declared amount. Added ingredients carry their own considerations, separate from nattokinase alone. This hub records combination formulas only where documented and does not claim that a combination is superior to nattokinase alone.

Documented testing & verification

Look for reported third-party testing, a named lab, or certifications — and note whether that is independent verification or a brand/retailer claim. HerbParlor records testing information as attributed and never upgrades a claim to independent verification.

Manufacturer & source transparency

A named manufacturer, a stated country of origin, and traceable sourcing are part of HerbParlor’s transparency scoring. Products that disclose more are easier to compare; products that disclose less are reported as such, not ranked against them.

Price per serving & value (VitaValue™)

VitaValue™ puts price next to a comparable quantity — cost per serving — so capsule count, serving size, and packaging cannot disguise the real cost. Use it to compare value only after the criteria above are acceptable to you.

Enough information to compare?

A meaningful comparison needs the declared potency (in FU where documented) or amount, the serving size, the ingredient list, and at least some documented testing or sourcing. If a product leaves these blank, it cannot be fairly compared yet — that is a fact about disclosure, not a judgment of the product itself.

1. 01

   Potency declared in FU where documented

   Whether the label states a Fibrinolytic Units (FU) value for the nattokinase. An FU value expresses enzyme activity, not weight, and a label that states FU is more specific about potency than one that lists only milligrams. This hub records FU where documented and does not invent or convert FU values. Compare FU values only across products that declare them, and do not treat FU and milligrams as interchangeable.

2. 02

   Amount per serving

   How much nattokinase a serving delivers, stated by weight (milligrams) and/or by potency (FU) where declared. Compare in a single consistent unit so two products are measured the same way. A higher amount or higher FU value is not automatically better — compare it alongside the serving size, formulation, and testing.

3. 03

   Serving size & servings per container

   A serving may be one capsule, one tablet, or more than one unit. Serving size and servings per container decide how many doses you are comparing and how long a container lasts — both feed the standardized value. Two products with the same “2000 FU” claim can differ if one serving is one capsule and the other is two.

4. 04

   Ingredient identity & formulation

   Whether the label names “nattokinase” clearly, and whether the product contains only nattokinase or adds other enzymes, vitamins, minerals, or botanical extracts. A combination product is a different formulation, not a stronger version of the same nattokinase. Compare the declared potency and the full ingredient list together.

5. 05

   Combination ingredients

   Where a product combines nattokinase with other ingredients, note what is added and at what declared amount. Added ingredients carry their own considerations, separate from nattokinase alone. This hub records combination formulas only where documented and does not claim that a combination is superior to nattokinase alone.

6. 06

   Additional ingredients & formulation transparency

   A clear ingredient list, named excipients, capsule or tablet material, and any added compounds are part of HerbParlor’s transparency scoring. Missing or vague disclosure is reported as unavailable, not silently treated as a failure or a pass.

7. 07

   Testing & certifications

   Whether the product reports third-party testing, a named lab, or certifications — and whether that is independent verification or a brand/retailer claim. These are recorded as attributed, never silently upgraded.

8. 08

   Standardized value

   VitaValue™ puts price next to a comparable quantity — cost per serving — so capsule count, serving size, and packaging don’t disguise the real cost. Use it to compare value only after the criteria above are acceptable to you.

These are HerbParlor’s existing tools, contextualised for nattokinase. Each one turns research into a shortlist you can act on — no sponsored rankings, no hidden ordering.

Every product below is a real, canonical record assessed with the same VitaScore™ rubric. Open any product for the full profile, or compare several side by side.

Editorial explainers that break down the labels, the chemistry, and the comparison framework behind this hub.

• How to Compare Supplements

  The general framework behind every HerbParlor comparison.

  Read article

• How to Verify Third-Party Testing

  What independent verification actually means — and what a claim is not.

  Read article

1. 01

   No sponsored rankings. Ever.

   HerbParlor sells nothing and takes no placement fees. Scores cannot be bought, influenced, or negotiated.

2. 02

   Testing information over label claims

   We note when products report third-party testing, and say so when a product reports none. A manufacturer or retailer claim is never treated as independent verification.

3. 03

   Affiliate-neutral

   Commercial relationships do not influence scores, ordering, or what appears on this hub. Retailer links appear only when verified and are kept separate from editorial analysis.

Is a higher FU nattokinase better?

This hub does not imply that a higher FU value is automatically better, more effective, or a recommended dose. Fibrinolytic Units (FU) express enzyme activity, not weight, and a higher declared potency is a label fact, not a quality ranking. Studied potencies and amounts vary by outcome and population. Compare the declared FU alongside the serving size, formulation, and testing, and discuss any specific potency with a healthcare professional.

What is the difference between FU and milligrams on a nattokinase label?

Milligrams describe how much nattokinase material a serving contains by weight; Fibrinolytic Units (FU) describe enzyme activity. They are different measures and are not interchangeable. Two products with the same milligram amount can differ in declared FU potency, and two products with the same FU value can differ in milligram weight. This hub does not invent conversions between them. Compare whichever values the labels actually declare.

What do nattokinase 2000 FU and 4000 FU mean?

“2000 FU” and “4000 FU” are declared potency values that appear on some nattokinase labels, expressing enzyme activity per serving. They are label facts to compare where documented. This hub does not imply that 2000 FU or 4000 FU is universally best for any outcome, and does not endorse any particular FU value. Compare the declared FU alongside the serving size, formulation, and testing.

Does nattokinase treat blood clots, high blood pressure, or heart disease?

No. This hub does not claim that any nattokinase supplement treats, prevents, or cures any condition, including blood clots, hypertension, stroke, heart disease, or cardiovascular disease. Nattokinase is described as a fibrinolytic enzyme and has been studied in laboratory, mechanistic, and a limited number of human studies, but human clinical evidence remains limited and most human studies measure surrogate outcomes (such as blood pressure or biomarkers) rather than clinical events. “Blood thinning,” “blood pressure support,” “circulation,” and “fibrinolytic” are not presented here as established treatment outcomes. Any use for a specific concern is a decision for a healthcare professional.

What does the latest research say about nattokinase?

The available human research on nattokinase is limited in size, duration, and the outcomes measured. Most human studies report surrogate or intermediate measures — blood pressure readings, coagulation or fibrinolytic biomarkers, and lipid or other blood markers — rather than clinical cardiovascular events. Some randomized trials and systematic reviews report changes in blood pressure measurements, but findings vary by study design, potency, amount, duration, and population, and are not consistent across all studies. The evidence does not establish nattokinase as effective for any specific health outcome, and no clinical-event prevention (stroke, heart attack, blood clots) has been demonstrated. This is a developing research area, not a settled one.

Does nattokinase lower blood pressure?

Some randomized trials and systematic reviews report changes in blood pressure measurements after nattokinase supplementation, but findings vary by study and are not consistent across all studies, and the evidence base is limited in size and duration. A measured change in a blood pressure reading is a surrogate outcome — it is not a diagnosis or treatment claim, is not the same as established antihypertensive efficacy, and does not by itself establish a reduction in strokes, heart attacks, or other cardiovascular events. This hub does not present nattokinase as a treatment or preventive therapy for hypertension, and does not present it as a substitute for prescribed blood-pressure medication. Any use for a blood-pressure concern is a decision for a healthcare professional.

Does nattokinase thin the blood?

The term “blood thinner” can be misleading. Nattokinase is described as a fibrinolytic enzyme and has been studied for activity related to fibrin breakdown, and some human studies have measured coagulation or fibrinolytic biomarkers. These are laboratory or mechanistic effects and surrogate biomarker changes, not established clinical anticoagulant or antiplatelet efficacy. This hub does not imply that nattokinase is equivalent to prescription anticoagulants or antiplatelet medicines, and does not present it as a substitute for such medications. Because of plausible bleeding concerns, anyone taking blood-thinning medication should discuss nattokinase use with the clinician managing that medication before starting.

Does nattokinase prevent blood clots?

No clinical-event prevention has been established by the available evidence. Laboratory and mechanistic studies show fibrinolytic activity, and some human studies report changes in coagulation or fibrinolytic biomarkers, but these are surrogate outcomes — measured blood values, not demonstrated prevention of dangerous blood clots. This hub does not claim that nattokinase prevents, dissolves, or treats blood clots, and does not present it as a substitute for prescribed anticoagulants or antiplatelet drugs. Whether nattokinase is appropriate for any clot-related concern is a decision for a healthcare professional.

Is nattokinase proven to protect the heart?

No. Cardiovascular protection, stroke prevention, heart-attack prevention, and clot prevention are claims that have been investigated, not established clinical outcomes for nattokinase. The available human research does not demonstrate a reduction in cardiovascular events; most studies measure surrogate or intermediate outcomes such as blood pressure or biomarkers, and a change in those measures does not automatically translate into fewer clinical events. This hub does not claim that nattokinase treats, prevents, or cures cardiovascular disease or atherosclerosis, and does not present it as guaranteed cardiovascular protection.

Can nattokinase interact with my medications?

Nattokinase may interact with blood-thinning medications such as warfarin and other anticoagulants or antiplatelet drugs, and has been studied in relation to blood pressure. Because of plausible bleeding concerns, anyone with a bleeding condition or a planned surgical or dental procedure should also discuss use with a healthcare professional. Discuss nattokinase use with the clinician or pharmacist managing your medications before starting.

What is the recommended nattokinase dosage?

There is no authoritative recommended daily intake or tolerable upper intake level for nattokinase. Potency is commonly expressed in FU where stated, and amounts vary by product. Any potency or amount used in research is a studied value, not a recommendation. Dosing for any clinical purpose — especially for people who take medications, are pregnant or nursing, have a bleeding condition, or are preparing for surgery — is a decision for a healthcare professional.

Is nattokinase the same as natto?

No. Natto is a traditional Japanese food made from fermented soybeans. Nattokinase is an enzyme associated with natto. Supplements contain nattokinase as an isolated ingredient, not the whole natto food. This hub does not claim that a nattokinase supplement is equivalent to eating natto or produces the same effects.